Fill in the form below and our experts will get back to you within 1 business day.
Accelerate your research with precision gene editing powered by CRISPR-Cas9, TALEN, ZFN, and emerging technologies. From gRNA design to cell line development, we deliver reliable genome engineering solutions for academic and industrial applications.
Trusted by leading research and pharmaceutical institutions
gRNA design, Cas9 delivery, knock-in/knockout
Precision nucleotide modifications
Stable cell line generation
From single gene knockouts to complex multi-genic modifications, our gene editing services provide researchers with the precision tools needed to advance their biological discoveries.
Industry-leading CRISPR-Cas9 editing with optimized gRNA design and delivery systems for high-efficiency genome modifications.
Next-generation precision editing technologies for single nucleotide modifications without double-strand breaks.
End-to-end cell line engineering services from concept to validated clonal cell lines.
Alternative nuclease platforms for applications requiring specific DNA binding characteristics.
Comprehensive off-target profiling to ensure the safety and specificity of your edited cells.
High-throughput CRISPR screening services for target discovery and functional genomics.
Our experts are here to help you design the optimal editing strategy for your project.
We employ a comprehensive suite of gene editing technologies to meet the diverse needs of your research projects.
Our CRISPR-Cas9 platform delivers high-efficiency genome editing with validated gRNA design algorithms and optimized delivery systems. We support both standard Cas9 and high-fidelity variants for applications requiring enhanced specificity.
AI-optimized algorithms for maximum on-target activity
Simultaneous modification of multiple targets
Up to 10 kb knock-in capacity
Cre-lox and FLP-FRT systems
Editing Efficiency
Precision Resolution
Our next-generation editing platforms enable precise single-nucleotide modifications without introducing double-strand breaks, dramatically reducing unwanted indels and improving product purity.
C to T conversions with high efficiency
A to G conversions for all contexts
All 12 substitution types without DSB
Transcription Activator-Like Effector Nucleases offer an alternative to CRISPR for applications requiring specific DNA binding properties or regulatory considerations.
Zinc Finger Nucleases provide another validated platform for permanent gene modification, particularly valuable for therapeutic applications.
Detailed specifications for our gene editing services to help you plan your experiments.
HEK293
HeLa
CHO
U2OS
HCT116
iPSC
Primary Cells
T Cells
Cytosine to Thymine conversions
Adenine to Guanine conversions
All 12 transition/transversion types
Minimal unwanted byproducts
Lipid-based transfection reagents
Nucleofection for difficult cell types
Lentivirus and AAV for stable expression
Pre-assembled Cas9-gRNA complexes
From initial consultation to validated results, our integrated workflow ensures efficient and reliable gene editing services.
Our experts review your project requirements and recommend the optimal editing strategy.
AI-optimized gRNA design and construct preparation for maximum editing efficiency.
Expert execution of editing experiments with comprehensive validation analysis.
Complete documentation package and ongoing technical support for your project.
Our gene editing services support diverse research applications across multiple fields.
Create cellular models of genetic diseases to study disease mechanisms and test therapeutic interventions.
Generate engineered cell lines for compound screening, target validation, and mechanism of action studies.
Systematic gene knockout and knock-in studies to elucidate gene function and regulatory networks.
Engineer cell lines for cell therapy applications including CAR-T and gene therapy vector production.
Introduce specific mutations to study protein function, optimize enzyme activity, or create fusion proteins.
Modify multiple genes simultaneously to engineer metabolic pathways for bioproduct synthesis.
See what our customers say about their gene editing service experience.
"The CRISPR knockout service exceeded our expectations. We achieved over 90% editing efficiency in our primary T cells, and the technical team was incredibly helpful throughout the project."
Research University
Metabolic Engineering Lab
"We needed a complex double knock-in for our drug discovery project. The team delivered validated clones with both insertions working perfectly. Exceptional service!"
Pharmaceutical Company
Drug Discovery
"The base editing service allowed us to create precise point mutations that would have been impossible with traditional CRISPR. The purity of our edited cell pools was remarkable."
Biotech Company
Research Lab
Our services are built on a foundation of rigorous scientific research and validated methodologies.
Qin H, Xu W, Yao K. Trends in Molecular Medicine. 2023
Comprehensive review of CRISPR-Cas gene editing technologies for therapeutic applications, covering base editing and prime editing advances.
View PublicationKang K, Song Y, Kim I, Kim TJ. Bioengineering. 2022
Review focusing on medical applications of CRISPR, including therapeutics for genetic diseases, oncology, and infectious disease.
View PublicationÇerçi B, Uzay IA, Kara MK, Dinçer P. Life Sciences. 2023
Analysis of clinical trials evaluating CRISPR/Cas systems for treating genetic diseases and promising preclinical research.
View PublicationRichardson C et al. Disease Models & Mechanisms. 2023
Overview of recent progress in optimizing precise genome editing methods and their potential for generating disease models.
View PublicationCarroll D. Annual Review of Biochemistry. 2014
Classic review of ZFN, TALEN, and CRISPR-Cas gene editing technologies and their comparative analysis.
View PublicationAnzalone AV et al. Nature Biotechnology. 2020
Comprehensive review of CRISPR-Cas nucleases, base editors, transposases, and prime editors for genome editing.
View PublicationFind answers to common questions about our gene editing services.
Get a customized quote for your Gene Editing Services project. Our experts will respond within 24 hours.
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.